Gold Kelly
SEC insider (Form 3/4/5 filer). CIK 0002033333. Chief Financial Officer at Camp4 Therapeutics Corp (CAMP) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in WATERTOWN, MA.
Companies Gold Kelly has filed insider reports for
- Camp4 Therapeutics Corp (CAMP): Officer, Chief Financial Officer
- X4 Pharmaceuticals, Inc (XFOR): Director
Gold Kelly
CIK: 0002033333
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 31, 2026CAMP
Camp4 Therapeutics Corp
PurchaseIndirect10K shares at avg. $3.96$40K - Aug 3, 2026CAMP
Camp4 Therapeutics Corp
PurchaseDirect6.6K shares at avg. $1.65$11K - Jul 1, 2026XFOR
X4 Pharmaceuticals, Inc
AwardDirectStock Option (right to buy)
110K shares- - Apr 1, 2026CAMP
Camp4 Therapeutics Corp
AwardDirectStock Option (Right to Buy)
215K shares- - Dec 11, 2025CAMP
Camp4 Therapeutics Corp
AwardDirectStock Option (Right to Buy)
190K shares- - Sep 11, 2025CAMP
Camp4 Therapeutics Corp
PurchaseDirect6.1K shares at avg. $1.65$10K - Apr 1, 2025CAMP
Camp4 Therapeutics Corp
AwardDirectStock Option (Right to Buy)
80K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 |  CAMP Camp4 Therapeutics Corp | Purchase | 10,000 | $3.96 | $39,600 | Indirect |
| Aug 3, 2026 | CAMP Camp4 Therapeutics Corp | Purchase | 6,551 | $1.65 | $10,809 | Direct |
| Jul 1, 2026 |  XFOR X4 Pharmaceuticals, Inc | Award Stock Option (right to buy) | 110,000 | - | - | Direct |
| Apr 1, 2026 | CAMP Camp4 Therapeutics Corp | Award Stock Option (Right to Buy) | 215,000 | - | - | Direct |
| Dec 11, 2025 | CAMP Camp4 Therapeutics Corp | Award Stock Option (Right to Buy) | 190,000 | - | - | Direct |
| Sep 11, 2025 | CAMP Camp4 Therapeutics Corp | Purchase | 6,060 | $1.65 | $9,999 | Direct |
| Apr 1, 2025 | CAMP Camp4 Therapeutics Corp | Award Stock Option (Right to Buy) | 80,000 | - | - | Direct |
1-7 of 7 transactions